價格 | ¥13800 | ¥10600 | ¥17500 |
包裝 | 50mg | 25mg | 100mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:化合物 HDAC1/MAO-B-IN-1 | 英文名稱:HDAC1/MAO-B-IN-1 |
CAS:2759855-37-1 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T60947 |
名稱 | HDAC1/MAO-B-IN-1 |
描述 | HDAC1/MAO-B-IN-1 has the potential to be used in the Alzheimer’s disease research. HDAC1/MAO-B-IN-1 is a potent and selective inhibitor of HDAC1/MAO-B that can cross the blood-brain barrier. The IC50 values of HDAC1/MAO-B-IN-1 for HDAC1 and MAO-B are 21.4 nM and 99.0 nM, respectively [1]. |
體外活性 | HDAC1/MAO-B-IN-1 (compound 1f) shows inhibitory activities with IC 50 s of 99.0 nM, 9923.0 nM, 21.4 nM for hMAO-B, hMAO-A, hHDAC1, respectively [1]. HDAC1/MAO-B-IN-1 (50 μM; 24 h) displays neuroprotective and inhibitory activity on ROS production in PC12 cells [1]. Cell Viability Assay [1] Cell Line: PC12 cells Concentration: 50 μM Incubation Time: 24 h Result: Displayed neuroprotective and inhibitory activity on ROS production. |
體內(nèi)活性 | HDAC1/MAO-B-IN-1 (20 mg/kg; i.g.) exhibits favorable BBB (blood–brain barrier) permeability [1]. HDAC1/MAO-B-IN-1 (15 mg/kg; i.p.) improves the learning and memory abilities of the ICR mice [1]. Animal Model: 6-8 weeks, ICR male mice [1] Dosage: 20 mg/kg Administration: I.g. Result: Exhibited favorable BBB (blood–brain barrier) permeability. Animal Model: 20-25 g, ICR female mice [1] Dosage: 15 mg/kg Administration: I.p.; 15 consecutive days Result: Improved the learning and memory abilities of the ICR mice. |
存儲條件 | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-10-15 | |
¥1000 |
VIP1年
|
康邁迪森(北京)醫(yī)藥科技有限公司
|
2024-09-11 | |
¥1280 |
VIP1年
|
湖北艾普蒂生物工程有限公司
|
2024-11-15 |